Takashi Tsuchiya Selected Research

Takashi Tsuchiya Research Topics

Disease

14	Neoplasms (Cancer) 01/2022 - 02/2002
12	Colorectal Neoplasms (Colorectal Cancer) 12/2022 - 12/2015
6	Inflammation (Inflammations) 12/2021 - 08/2012
5	Osteosarcoma (Osteogenic Sarcoma) 06/2014 - 01/2004
4	Colonic Neoplasms (Colon Cancer) 02/2022 - 06/2014
3	Stomach Neoplasms (Stomach Cancer) 12/2020 - 08/2002
3	Stomatitis 12/2020 - 01/2018
3	Neoplasm Metastasis (Metastasis) 12/2020 - 01/2006
2	Carcinoma (Carcinomatosis) 02/2022 - 01/2002
2	Breast Neoplasms (Breast Cancer) 12/2020 - 01/2006
2	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 12/2020 - 12/2016
2	Peripheral Nervous System Diseases (PNS Diseases) 10/2020 - 01/2020
2	Hand-Foot Syndrome 08/2020 - 01/2018
2	Anorexia 08/2020 - 01/2018
2	Chondrosarcoma 07/2016 - 10/2011
2	Glioma (Gliomas) 06/2014 - 12/2013
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 06/2014 - 12/2013
2	Sarcoma (Soft Tissue Sarcoma) 01/2004 - 01/2003
1	Mucinous Adenocarcinoma (Mucinous Carcinoma) 02/2022
1	Sarcopenia 01/2022
1	Insulinoma 12/2021
1	Alcoholic Hepatitis 01/2021
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2021
1	Liver Diseases (Liver Disease) 01/2021
1	Lymphatic Metastasis 01/2021
1	Diarrhea 08/2020
1	Radiation Injuries (Radiation Sickness) 08/2020
1	Seroma 01/2020
1	Hyperalgesia 01/2020
1	Giant Cell Tumor of Bone 06/2014
1	Neurofibrosarcoma (MPNST) 01/2014
1	Carcinogenesis 01/2014
1	Wounds and Injuries (Trauma) 08/2012
1	Infections 07/2012
1	Insulin Resistance 06/2012
1	Cleidocranial Dysplasia (Cleidocranial Dysostosis) 10/2011
1	Rhabdomyosarcoma 09/2011
1	Necrosis 09/2011
1	Pain (Aches) 03/2009
1	Synovial Sarcoma (Synovioma) 03/2009
1	Head and Neck Neoplasms (Head and Neck Cancer) 01/2009
1	Adenocarcinoma 01/2009

Drug/Important Bio-Agent (IBA)

10	Cystine (L-Cystine)IBA 12/2021 - 08/2012
10	theanineIBA 12/2021 - 08/2012
4	Leucovorin (Folinic Acid)FDA Link 02/2022 - 06/2014
3	TegafurIBA 02/2022 - 06/2014
3	UracilIBA 02/2022 - 06/2014
3	Amino Acids FDA Link 12/2020 - 05/2013
3	Glutathione (Reduced Glutathione)IBA 08/2020 - 08/2012
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 10/2020 - 01/2020
2	Capecitabine (Xeloda)FDA Link 08/2020 - 01/2018
2	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 06/2014 - 12/2013
2	Glucose (Dextrose)FDA LinkGeneric 06/2012 - 03/2006
2	Messenger RNA (mRNA)IBA 10/2011 - 02/2002
2	Pamidronate (Aredia)FDA LinkGeneric 03/2009 - 01/2006
2	Cadherins (E-Cadherin)IBA 08/2002 - 01/2002
1	imidazoleacetic acid (IMAC)IBA 01/2022
1	Tumor Viral Antigens (Large T Antigen)IBA 12/2021
1	Insulin (Novolin)FDA Link 12/2021
1	Toll-Like Receptor 7IBA 01/2021
1	GlobulinsIBA 01/2021
1	Ethanol (Ethyl Alcohol)IBA 01/2021
1	Pattern Recognition ReceptorsIBA 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	LigandsIBA 01/2021
1	Interleukin-22 (IL-22)IBA 01/2021
1	AlbuminsIBA 01/2021
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 12/2020
1	S-1 plus cisplatinIBA 12/2020
1	Fluorouracil (Carac)FDA LinkGeneric 10/2020
1	Indicators and Reagents (Reagents)IBA 03/2020
1	Hematoxylin (Haematoxylon)IBA 05/2017
1	Eosine Yellowish-(YS) (Eosin)IBA 05/2017
1	TitaniumIBA 07/2016
1	CaspasesIBA 01/2014
1	ProstaglandinsIBA 01/2014
1	Etodolac (Lodine)FDA LinkGeneric 01/2014
1	Arachidonic Acid (Vitamin F)IBA 01/2014
1	EnzymesIBA 01/2014
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2014
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 01/2014
1	DNA (Deoxyribonucleic Acid)IBA 12/2013
1	Monoclonal AntibodiesIBA 12/2013
1	OligosaccharidesIBA 07/2012
1	LeptinIBA 06/2012
1	Proteins (Proteins, Gene)FDA Link 10/2011
1	MucinsIBA 10/2010

Therapy/Procedure

9	Oral Administration 01/2021 - 08/2012
8	Adjuvant Chemotherapy 02/2022 - 06/2014
6	Stents 12/2022 - 03/2019
5	Therapeutics 01/2021 - 01/2018
5	Drug Therapy (Chemotherapy) 12/2020 - 01/2004
4	Self Expandable Metallic Stents 12/2022 - 03/2019
3	Length of Stay 01/2021 - 09/2018
2	Gastrectomy 09/2018 - 05/2013
1	Decompression 03/2019
1	Drug Tapering 01/2018
1	Perioperative Period 05/2013
1	Aftercare (After-Treatment) 03/2009
1	Pancreaticoduodenectomy 01/2009